| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coccidioides | 47 | 2025 | 55 | 9.100 |
Why?
|
| Coccidioidomycosis | 40 | 2025 | 53 | 8.470 |
Why?
|
| Fungal Vaccines | 26 | 2020 | 44 | 4.590 |
Why?
|
| Antigens, Fungal | 12 | 2019 | 33 | 1.990 |
Why?
|
| CARD Signaling Adaptor Proteins | 6 | 2020 | 11 | 1.480 |
Why?
|
| Arabidopsis | 5 | 2023 | 102 | 1.420 |
Why?
|
| Plant Proteins | 5 | 2017 | 100 | 1.230 |
Why?
|
| Plants, Genetically Modified | 9 | 2022 | 50 | 1.110 |
Why?
|
| Mice | 46 | 2024 | 6490 | 1.080 |
Why?
|
| Antifungal Agents | 3 | 2025 | 169 | 1.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2016 | 15 | 1.050 |
Why?
|
| Antibodies, Fungal | 8 | 2019 | 24 | 1.040 |
Why?
|
| Adjuvants, Immunologic | 4 | 2019 | 117 | 1.020 |
Why?
|
| T-Lymphocytes | 6 | 2017 | 378 | 0.980 |
Why?
|
| Araceae | 3 | 2017 | 3 | 0.900 |
Why?
|
| Lung | 8 | 2020 | 484 | 0.830 |
Why?
|
| Animals | 51 | 2024 | 16695 | 0.800 |
Why?
|
| HLA-DR4 Antigen | 3 | 2018 | 20 | 0.790 |
Why?
|
| Immunity, Innate | 4 | 2019 | 168 | 0.790 |
Why?
|
| GTP Cyclohydrolase | 1 | 2022 | 4 | 0.790 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 45 | 0.780 |
Why?
|
| Lectins, C-Type | 3 | 2020 | 37 | 0.780 |
Why?
|
| Huntington Disease | 1 | 2022 | 31 | 0.770 |
Why?
|
| Glucans | 2 | 2019 | 8 | 0.750 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 32 | 0.720 |
Why?
|
| Mice, Inbred C57BL | 21 | 2021 | 1804 | 0.720 |
Why?
|
| Flowers | 2 | 2023 | 20 | 0.710 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2017 | 59 | 0.670 |
Why?
|
| Recombinant Proteins | 13 | 2021 | 522 | 0.670 |
Why?
|
| Flow Cytometry | 3 | 2024 | 411 | 0.660 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 11 | 0.660 |
Why?
|
| Erythropoietin | 5 | 2021 | 36 | 0.650 |
Why?
|
| Chitin | 3 | 2019 | 20 | 0.650 |
Why?
|
| Gene Expression Regulation, Plant | 4 | 2017 | 65 | 0.640 |
Why?
|
| Serologic Tests | 3 | 2019 | 45 | 0.640 |
Why?
|
| Precipitins | 1 | 2019 | 1 | 0.630 |
Why?
|
| Saccharomycetales | 1 | 2019 | 8 | 0.630 |
Why?
|
| Vaccines, Attenuated | 7 | 2016 | 75 | 0.620 |
Why?
|
| Vaccines, Subunit | 3 | 2019 | 34 | 0.620 |
Why?
|
| Th1 Cells | 4 | 2018 | 97 | 0.610 |
Why?
|
| Cytokines | 12 | 2020 | 661 | 0.600 |
Why?
|
| Protozoan Vaccines | 1 | 2018 | 16 | 0.590 |
Why?
|
| Interferon-gamma | 3 | 2016 | 268 | 0.570 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2016 | 128 | 0.560 |
Why?
|
| Phagocytosis | 4 | 2024 | 83 | 0.520 |
Why?
|
| Gibberellins | 1 | 2016 | 7 | 0.510 |
Why?
|
| Fungal Proteins | 8 | 2019 | 143 | 0.500 |
Why?
|
| Genes, Plant | 2 | 2016 | 22 | 0.500 |
Why?
|
| Nitric Oxide | 3 | 2018 | 381 | 0.490 |
Why?
|
| Molecular Sequence Data | 18 | 2014 | 1559 | 0.480 |
Why?
|
| Amino Acid Sequence | 13 | 2017 | 1188 | 0.480 |
Why?
|
| Indoleacetic Acids | 2 | 2014 | 12 | 0.450 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 221 | 0.450 |
Why?
|
| Immunologic Memory | 2 | 2013 | 41 | 0.440 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2014 | 4 | 0.430 |
Why?
|
| Plant Growth Regulators | 1 | 2014 | 16 | 0.430 |
Why?
|
| Lung Diseases, Fungal | 5 | 2020 | 21 | 0.430 |
Why?
|
| Gene Deletion | 3 | 2018 | 168 | 0.430 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 29 | 0.420 |
Why?
|
| Interleukin-10 | 1 | 2013 | 86 | 0.410 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2012 | 13 | 0.390 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 658 | 0.380 |
Why?
|
| Complement C5a | 1 | 2012 | 2 | 0.380 |
Why?
|
| Alkaloids | 1 | 2012 | 46 | 0.380 |
Why?
|
| Astragalus Plant | 1 | 2012 | 1 | 0.380 |
Why?
|
| Signal Transduction | 6 | 2020 | 2111 | 0.370 |
Why?
|
| Hygromycin B | 1 | 2012 | 1 | 0.370 |
Why?
|
| Selenium Compounds | 1 | 2012 | 11 | 0.370 |
Why?
|
| Phleomycins | 1 | 2012 | 2 | 0.370 |
Why?
|
| Cinnamates | 1 | 2012 | 7 | 0.370 |
Why?
|
| Drug Resistance, Fungal | 1 | 2012 | 33 | 0.370 |
Why?
|
| Mice, Knockout | 9 | 2016 | 1010 | 0.370 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2010 | 71 | 0.360 |
Why?
|
| Th2 Cells | 1 | 2011 | 63 | 0.360 |
Why?
|
| Genetic Markers | 1 | 2012 | 146 | 0.350 |
Why?
|
| Interleukin-17 | 5 | 2016 | 53 | 0.350 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2018 | 293 | 0.350 |
Why?
|
| Cryptococcus neoformans | 2 | 2024 | 62 | 0.350 |
Why?
|
| Plant Leaves | 4 | 2017 | 134 | 0.350 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 1554 | 0.330 |
Why?
|
| Humans | 34 | 2025 | 42163 | 0.330 |
Why?
|
| Vaccines, Synthetic | 8 | 2018 | 78 | 0.330 |
Why?
|
| Selenium | 1 | 2012 | 150 | 0.320 |
Why?
|
| Regeneration | 1 | 2010 | 29 | 0.320 |
Why?
|
| Lymphocyte Activation | 6 | 2016 | 244 | 0.320 |
Why?
|
| Nicotine | 1 | 2012 | 290 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 12 | 2019 | 686 | 0.310 |
Why?
|
| Macrophages | 4 | 2020 | 515 | 0.300 |
Why?
|
| Peptides | 3 | 2023 | 357 | 0.290 |
Why?
|
| Folic Acid | 2 | 2022 | 49 | 0.290 |
Why?
|
| Vaccination | 5 | 2016 | 332 | 0.280 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2025 | 122 | 0.280 |
Why?
|
| Candida albicans | 2 | 2018 | 173 | 0.250 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 15 | 0.240 |
Why?
|
| Receptors, Interleukin-17 | 3 | 2016 | 9 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 271 | 0.230 |
Why?
|
| beta-Glucosidase | 2 | 2001 | 6 | 0.220 |
Why?
|
| Small Molecule Libraries | 1 | 2025 | 60 | 0.220 |
Why?
|
| Survival Analysis | 5 | 2018 | 362 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 1066 | 0.220 |
Why?
|
| Receptors, Interferon | 2 | 2016 | 14 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2025 | 232 | 0.220 |
Why?
|
| Female | 16 | 2020 | 24018 | 0.210 |
Why?
|
| Drug Discovery | 1 | 2025 | 106 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2019 | 456 | 0.210 |
Why?
|
| Mycoses | 2 | 2016 | 31 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 649 | 0.210 |
Why?
|
| Asialoglycoproteins | 2 | 2014 | 3 | 0.210 |
Why?
|
| Spores, Fungal | 3 | 2016 | 21 | 0.210 |
Why?
|
| Pollen | 1 | 2023 | 5 | 0.210 |
Why?
|
| Cryptococcosis | 2 | 2024 | 43 | 0.210 |
Why?
|
| Urease | 3 | 2013 | 16 | 0.210 |
Why?
|
| Cell Wall | 3 | 2006 | 55 | 0.200 |
Why?
|
| Blastomyces | 2 | 2014 | 2 | 0.200 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2022 | 9 | 0.200 |
Why?
|
| Cysteine | 1 | 2023 | 101 | 0.200 |
Why?
|
| Acinetobacter baumannii | 1 | 2022 | 35 | 0.190 |
Why?
|
| Cross Infection | 1 | 2022 | 47 | 0.190 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 205 | 0.190 |
Why?
|
| Base Sequence | 6 | 2014 | 997 | 0.190 |
Why?
|
| Carbon | 1 | 2022 | 127 | 0.180 |
Why?
|
| Virulence | 7 | 2018 | 238 | 0.180 |
Why?
|
| Proteomics | 2 | 2022 | 363 | 0.180 |
Why?
|
| Antigen-Presenting Cells | 2 | 2012 | 31 | 0.170 |
Why?
|
| Immunoglobulin M | 1 | 2001 | 87 | 0.170 |
Why?
|
| Southwestern United States | 2 | 2019 | 47 | 0.170 |
Why?
|
| Genetic Engineering | 1 | 2020 | 36 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 6 | 2012 | 508 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2020 | 70 | 0.160 |
Why?
|
| Macrophage Activation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Biofilms | 2 | 2018 | 178 | 0.160 |
Why?
|
| Neutrophils | 3 | 2016 | 141 | 0.160 |
Why?
|
| Lipids | 1 | 2021 | 256 | 0.150 |
Why?
|
| Drug Carriers | 1 | 2020 | 169 | 0.150 |
Why?
|
| Tularemia | 2 | 2018 | 115 | 0.150 |
Why?
|
| Gold | 1 | 2020 | 153 | 0.150 |
Why?
|
| Immunoblotting | 4 | 2012 | 181 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 22 | 0.150 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 52 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 267 | 0.150 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 273 | 0.150 |
Why?
|
| Phagocytes | 2 | 2024 | 7 | 0.140 |
Why?
|
| Antigens, Protozoan | 1 | 2018 | 74 | 0.140 |
Why?
|
| Phagosomes | 1 | 2018 | 33 | 0.140 |
Why?
|
| Zea mays | 1 | 2019 | 74 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2018 | 44 | 0.140 |
Why?
|
| Amides | 1 | 2018 | 72 | 0.140 |
Why?
|
| Mutagenesis | 2 | 2012 | 92 | 0.140 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 318 | 0.130 |
Why?
|
| Stroke | 1 | 2021 | 348 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 227 | 0.130 |
Why?
|
| Vaccines, Inactivated | 1 | 2017 | 16 | 0.130 |
Why?
|
| Protein Binding | 2 | 2018 | 1076 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 36 | 0.130 |
Why?
|
| Formaldehyde | 1 | 2017 | 30 | 0.130 |
Why?
|
| Molecular Weight | 3 | 2002 | 168 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 63 | 0.130 |
Why?
|
| Meristem | 1 | 2016 | 6 | 0.130 |
Why?
|
| Male | 5 | 2020 | 22779 | 0.130 |
Why?
|
| Histoplasma | 2 | 2014 | 6 | 0.130 |
Why?
|
| Oligopeptides | 2 | 2014 | 108 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2017 | 103 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 518 | 0.120 |
Why?
|
| Interleukins | 1 | 2016 | 37 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2016 | 37 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 71 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2014 | 148 | 0.120 |
Why?
|
| Respiratory Tract Infections | 2 | 2006 | 36 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 454 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2020 | 255 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 206 | 0.120 |
Why?
|
| Calnexin | 1 | 2015 | 1 | 0.120 |
Why?
|
| Francisella tularensis | 1 | 2016 | 116 | 0.110 |
Why?
|
| Epoetin Alfa | 1 | 2014 | 2 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 183 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 727 | 0.110 |
Why?
|
| Ascomycota | 1 | 2015 | 21 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 276 | 0.110 |
Why?
|
| Bacterial Vaccines | 1 | 2016 | 129 | 0.110 |
Why?
|
| Blotting, Southern | 4 | 2002 | 68 | 0.110 |
Why?
|
| Biochemistry | 1 | 2014 | 12 | 0.110 |
Why?
|
| Genome, Fungal | 3 | 2010 | 28 | 0.110 |
Why?
|
| Gene Expression | 5 | 2020 | 692 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 203 | 0.110 |
Why?
|
| Epitopes | 1 | 2015 | 155 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 534 | 0.110 |
Why?
|
| Computational Biology | 1 | 2017 | 324 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2012 | 195 | 0.110 |
Why?
|
| Blastomycosis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Histoplasmosis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Immunity, Active | 1 | 2013 | 6 | 0.110 |
Why?
|
| Multigene Family | 1 | 2014 | 105 | 0.110 |
Why?
|
| Endemic Diseases | 1 | 2014 | 22 | 0.110 |
Why?
|
| Plant Roots | 2 | 2014 | 180 | 0.100 |
Why?
|
| Amidine-Lyases | 1 | 2013 | 1 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 91 | 0.100 |
Why?
|
| Genes, Fungal | 3 | 2002 | 34 | 0.100 |
Why?
|
| Light | 1 | 2014 | 182 | 0.100 |
Why?
|
| Ammonia | 1 | 2013 | 22 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2018 | 722 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2018 | 449 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2012 | 90 | 0.100 |
Why?
|
| Methylation | 1 | 2012 | 118 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 25 | 0.100 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2012 | 14 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 979 | 0.090 |
Why?
|
| DNA, Plant | 1 | 2012 | 10 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 99 | 0.090 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2024 | 11 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 2012 | 73 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 167 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2014 | 884 | 0.090 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2011 | 10 | 0.090 |
Why?
|
| RNA Interference | 1 | 2012 | 246 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 173 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 26 | 0.090 |
Why?
|
| Glycosylation | 3 | 2020 | 111 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2008 | 36 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2014 | 548 | 0.090 |
Why?
|
| Protein Engineering | 2 | 2014 | 47 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 160 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 134 | 0.080 |
Why?
|
| Hybridization, Genetic | 1 | 2010 | 24 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 50 | 0.080 |
Why?
|
| Succinimides | 1 | 2009 | 9 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 2009 | 5 | 0.080 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2010 | 36 | 0.080 |
Why?
|
| Mitosporic Fungi | 1 | 2009 | 5 | 0.080 |
Why?
|
| Hydrazones | 1 | 2009 | 11 | 0.080 |
Why?
|
| Niacinamide | 1 | 2009 | 16 | 0.080 |
Why?
|
| Ovalbumin | 1 | 2009 | 47 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2020 | 385 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 160 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 49 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1679 | 0.080 |
Why?
|
| Abscisic Acid | 1 | 2008 | 6 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1420 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2010 | 452 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2009 | 165 | 0.070 |
Why?
|
| Vaccines | 1 | 2009 | 64 | 0.070 |
Why?
|
| Spleen | 3 | 2016 | 199 | 0.070 |
Why?
|
| Mutation | 4 | 2006 | 1169 | 0.070 |
Why?
|
| Transformation, Genetic | 3 | 2002 | 21 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2010 | 299 | 0.070 |
Why?
|
| Candidiasis | 2 | 2018 | 86 | 0.070 |
Why?
|
| Arginase | 1 | 2007 | 14 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1265 | 0.070 |
Why?
|
| Immune System | 1 | 2007 | 40 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2007 | 127 | 0.060 |
Why?
|
| Colony Count, Microbial | 3 | 2011 | 67 | 0.060 |
Why?
|
| Melanins | 1 | 2006 | 42 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2007 | 119 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gravitropism | 1 | 2005 | 6 | 0.060 |
Why?
|
| Immunization | 3 | 2019 | 93 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 729 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2006 | 19 | 0.060 |
Why?
|
| Opsonin Proteins | 1 | 2005 | 1 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2005 | 33 | 0.060 |
Why?
|
| Fungi | 1 | 2005 | 103 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 661 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 683 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2024 | 6 | 0.050 |
Why?
|
| Cryptococcus | 1 | 2024 | 10 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 71 | 0.050 |
Why?
|
| Escherichia coli | 3 | 2019 | 461 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 711 | 0.050 |
Why?
|
| Glucan Endo-1,3-beta-D-Glucosidase | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cell Survival | 2 | 2017 | 934 | 0.050 |
Why?
|
| Respiratory System | 1 | 2002 | 31 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 51 | 0.050 |
Why?
|
| Collagen Type IV | 1 | 2002 | 48 | 0.050 |
Why?
|
| Laminin | 1 | 2002 | 58 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 102 | 0.050 |
Why?
|
| Fibronectins | 1 | 2002 | 69 | 0.050 |
Why?
|
| Gene Order | 2 | 2013 | 17 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2002 | 129 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 24 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 51 | 0.040 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 54 | 0.040 |
Why?
|
| DNA, Fungal | 3 | 2009 | 47 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 72 | 0.040 |
Why?
|
| Chitin Synthase | 1 | 2001 | 4 | 0.040 |
Why?
|
| Glucosyltransferases | 1 | 2001 | 7 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 109 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 301 | 0.040 |
Why?
|
| Polyethyleneimine | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2016 | 633 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2014 | 420 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 174 | 0.040 |
Why?
|
| Genome, Plant | 1 | 2020 | 29 | 0.040 |
Why?
|
| Ornithine Decarboxylase | 1 | 2000 | 10 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 57 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2020 | 95 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 110 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2000 | 50 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 79 | 0.040 |
Why?
|
| Immunodominant Epitopes | 2 | 2011 | 28 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 42 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 239 | 0.040 |
Why?
|
| Hyphae | 1 | 2018 | 36 | 0.040 |
Why?
|
| Plankton | 1 | 2018 | 13 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 436 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gene Library | 1 | 2018 | 60 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2018 | 17 | 0.040 |
Why?
|
| Mycobacterium Infections | 1 | 2018 | 16 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 34 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2018 | 75 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 107 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 189 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 55 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 247 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 143 | 0.030 |
Why?
|
| Transfection | 1 | 2018 | 526 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2016 | 27 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2016 | 51 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 60 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2016 | 90 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 152 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2010 | 429 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 774 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 67 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 198 | 0.030 |
Why?
|
| Animals, Congenic | 1 | 2014 | 11 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2014 | 8 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 50 | 0.030 |
Why?
|
| Staurosporine | 1 | 2013 | 38 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 36 | 0.030 |
Why?
|
| Phylogeny | 2 | 2009 | 740 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 1452 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2014 | 130 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2013 | 226 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 116 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 277 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 22 | 0.020 |
Why?
|
| Receptors, Erythropoietin | 1 | 2012 | 6 | 0.020 |
Why?
|
| Paracoccidioidomycosis | 1 | 2011 | 4 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 154 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 230 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 68 | 0.020 |
Why?
|
| North America | 1 | 2011 | 85 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 973 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2011 | 124 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 35 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 99 | 0.020 |
Why?
|
| Metagenomics | 1 | 2010 | 43 | 0.020 |
Why?
|
| Synteny | 1 | 2009 | 18 | 0.020 |
Why?
|
| Onygenales | 1 | 2009 | 2 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2009 | 22 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1586 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2009 | 75 | 0.020 |
Why?
|
| Droughts | 1 | 2008 | 29 | 0.020 |
Why?
|
| California | 1 | 2010 | 531 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 1416 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 382 | 0.020 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2007 | 7 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 310 | 0.020 |
Why?
|
| Proline | 1 | 2007 | 39 | 0.020 |
Why?
|
| Genomics | 1 | 2009 | 289 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1848 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 31 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1617 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2598 | 0.020 |
Why?
|
| Water | 1 | 2008 | 314 | 0.020 |
Why?
|
| Neurons | 1 | 2013 | 1246 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 15 | 0.020 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 12 | 0.020 |
Why?
|
| Vacuoles | 1 | 2006 | 22 | 0.020 |
Why?
|
| Plant Shoots | 1 | 2005 | 25 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 78 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2005 | 98 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 487 | 0.010 |
Why?
|
| Gene Conversion | 1 | 2005 | 2 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2005 | 10 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 860 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 96 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 279 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 200 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 295 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2001 | 17 | 0.010 |
Why?
|
| Serial Passage | 1 | 2000 | 5 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 76 | 0.010 |
Why?
|
| Culture Media | 1 | 2000 | 96 | 0.010 |
Why?
|
| Putrescine | 1 | 2000 | 26 | 0.010 |
Why?
|
| Mitosis | 1 | 2000 | 112 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 273 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 303 | 0.010 |
Why?
|